Reviva Pharmaceuticals Holdings - Warrants (25/12/2025) Other Current Liabilities

The latest other current liabilities for RVPHW is $3.3T as of June 2026. That compares with $7M in the prior-year period — up 47647136.3% year over year. Investors often review this figure alongside Reviva Pharmaceuticals Holdings - Warrants (25/12/2025)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, RVPHW's other current liabilities moved from $7M to $3.3T — a 47647136.3% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Reviva Pharmaceuticals Holdings - Warrants (25/12/2025)'s operating scale or balance-sheet position.

A other current liabilities figure of $3.3T for RVPHW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting RVPHW's other current liabilities ($3.3T), review year-over-year change from $7M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Reviva Pharmaceuticals Holdings - Warrants (25/12/2025)'s other current liabilities against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.